Australian Dollar (AUD) Outlook: Testing Significant Resistance Against US Dollar (USD) The Australian Dollar (AUD) has been making steady gains against its US counterpart, the US Dollar (USD), in recent weeks. According to UOB Group’s FX strategists Quek Ser Leang and Peter Chia, the AUD/USD pair could test the significant resistance level of 0.6410 in…
Zeekr Group’s Autonomous SUV: A New Milestone in the Smart Driving Tech Race On a Tuesday morning, China’s Zeekr Group made an exciting announcement that is set to redefine the automotive industry. The company revealed plans to commence sales of its latest sports utility vehicle (SUV), equipped with advanced technology that will enable the car…
Candel Therapeutics Appoints Renowned Cancer Immunology Expert to Research Advisory Board NEEDHAM, Mass., March 18, 2025 – Candel Therapeutics, Inc. (Candel or the Company), a pioneering clinical stage biopharmaceutical company dedicated to advancing multimodal biological immunotherapies to help patients battle cancer, is thrilled to announce the addition of Elizabeth M. Jaffee, M.D., to its esteemed…
Delving Deeper into Bond Yields: How the U.S. Central Bank’s Decision Affects You and the World Bond yields have been a topic of great interest lately, as investors anxiously await the U.S. Federal Reserve’s (Fed) decision on how to address recent signs of a slowing economy. Let’s explore this intriguing financial phenomenon and discuss its…
Alzamend Neuro Initiates Phase II Clinical Trial for Next-Generation Lithium Treatment of Major Depressive Disorder at Mass. General Hospital Alzamend Neuro, a clinical-stage biopharmaceutical company focusing on the development of next-generation treatments for neuropsychiatric disorders, recently announced the initiation of a phase II clinical trial for its proprietary next-generation lithium formulation, ALZ-801, for the treatment…
AI16Z’s Eliza v2 Beta: A New Lease of Life Amidst Financial Challenges In a recent development, the much-anticipated ElizaOS v2 1.0 beta has been officially released by AI16Z, the artificial intelligence-focused investment firm founded by Peter Thiel and Andrew Ng. This announcement came amidst continued financial struggles for the company, which has been in the…
Nano Labs Ltd Reports Earnings for the First Half of 2024 On March 18, 2025, Nano Labs Ltd, a prominent fabless integrated circuit design company based in China, made an important announcement regarding its financial results for the six months ended December 31, 2024. The Company, trading on Nasdaq under the symbol “NA,” will release…
Get Ready for an Exciting Earnings Call: Milpitas-Based Tech Giant Set to Reveal Q1 2025 Financial Results Mark your calendars, tech enthusiasts! A major player in the Silicon Valley scene has just announced an upcoming earnings call. The event is scheduled for 7:00 p.m. ET on March 26, 2025, and the anticipation is palpable. The…
